Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

These scientists sought to answer a simple question. They ended up stumbling upon a discovery that could pave the way for a ...

Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...

Pfizer’s sasanlimab, when used with standard of care, reduced the likelihood of disease recurrence or progression, death due ...

Through funding from Student Council, students are now able to receive free STI testing with SHW which includes tests for HIV ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer ...

Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Penyakit Roseola Infantum biasa mengincar bayi dan balita. Pelajari penyebab dan gejalanya sebelum terlambat demi kesehatan ...

The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Vaccination plays a pivotal role in a child's early development by protecting them from serious illnesses. Here, the expert ...